New treatment attacks liver disease and type 2 diabetes

Published: 2017-03-07


A research team involving Adil Mardinoglu and Mathias Uhlén at KTH Royal Institute of Technology/SciLifeLab are planning a clinical trial of a new treatment for nonalcoholic fatty liver disease and type 2 diabetes. The treatment harnesses liver cells’ own ability to burn accumulated fats.

The team used a metabolic modeling approach, which relied on data from the Human Protein Atlas project, which also involved a number of researchers connected to SciLifeLab. The study was was published in Molecular Systems Biology.

Adil Mardinoglu, first author of the paper.

Adil Mardinoglu, first author of the paper.

Mathias Uhlén

Mathias Uhlén, co-author of the paper.